Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension

• Status: Completed
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This observational study is designed to evaluate the effects of Twynsta tablets with life style modifications on blood pressure, quality of life, and other risk factors in Korean patients with hypertension in a routine clinical practice setting.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Amlodipine; Telmisartan

Criteria

Inclusion criteria:

1. Patients with essential hypertension whose blood pressure is not adequately controlled by amlodipine or telmisartan monotherapy (=140/90 mmHg, = 130/80 mmHg for those with diabetes or kidney disease)

2. Age = 19 years at enrollment

3. Male or female patient (or legally acceptable representative) willing and able to provide written informed consent

Exclusion criteria:

1. Patients with previous exposure to Twynsta

2. Patients with hypersensitivity to the active substances, or to dihydropyridine derivatives

3. Female patients at second and third trimesters of pregnancy

4. Female patients with lactation

5. Patients with biliary obstructive disorders

6. Patients with severe hepatic impairment

7. Patients with high grade aortic stenosis

8. Patients with shock

9. Patients with hereditary conditions such as intolerance with excipient of the products

10. Current participation in other clinical trials or observational studies